Soleus Capital Management »

Bausch Lomb Corp shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Bausch Lomb Corp (BLCO) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Bausch Lomb Corp

Tip: Access up to 7 years of quarterly data

All positions including Bausch Lomb Corp held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bausch Lomb Corp by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.2M 121k 18.06
2024-09-30 $6.0M 312k 19.29

More positions owned by Soleus Capital Management

Spdr Ser Tr S&p Biotech Call Option (XBI)
Novocure Ord Shs (NVCR)
Tg Therapeutics (TGTX)
BioMarin Pharmaceutical (BMRN)
Krystal Biotech (KRYS)
Grifols S A Sp Adr Rep B Nvt (GRFS)
Axogen (AXGN)
Iovance Biotherapeutics (IOVA)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Terns Pharmaceuticals (TERN)
Organogenesis Hldgs (ORGO)
Nurix Therapeutics (NRIX)
United Therapeutics Corporation (UTHR)
Celcuity (CELC)
Syndax Pharmaceuticals (SNDX)

View all positions for Soleus Capital Management

Top funds holding Bausch Lomb Corp

Deutsche Bank Aktiengesellschaft
Carl C. Icahn, Individual
Alberta Investment Management Corporation
GoldenTree Asset Management
Maple Rock Capital Partners
D. E. Shaw & Co
Nomura Holdings
Arrowstreet Capital, Limited Partnership
River Road Asset Management
Whitebox Advisors
UBS Group
Mangrove Partners
Clearline Capital
Canada Pension Plan Investment Board
Compass Rose Asset Management

View all funds holding Bausch Lomb Corp

OSZAR »